These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6373217

  • 1. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühl U.
    Dtsch Med Wochenschr; 1984 May 11; 109(19):745-50. PubMed ID: 6373217
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R, Valentin A, Stöllberger C, Slany J.
    Angiology; 1988 Mar 11; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A, Neiss A.
    Vasa Suppl; 1988 Mar 11; 24():27-32. PubMed ID: 3062823
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
    Becker HM, Elert O, Häring R, Maurer PC, Raithel D, Sperling M, Stockmann U, Storz LW, Hirche H.
    Med Welt; 1979 Oct 26; 30(43):1602-6. PubMed ID: 514039
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1131-4. PubMed ID: 823407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG, Pini M, Moratti A, Paolicelli M, Basevi P, Quintavalla R, Manotti C, Di Lecce C.
    Angiology; 1989 Apr 03; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W, Hirche H, Barmeyer J, Schümichen C, Hoffmann G.
    Med Welt; 1979 Feb 16; 30(7):269-72. PubMed ID: 372733
    [No Abstract] [Full Text] [Related]

  • 20. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G, Perna S, Sabbá C, Martone VD, Condorelli M.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1411-6. PubMed ID: 7594063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.